Profile for Pluristem Therapeutics Inc. (PSTI)

$ 4.08   0.08 (+2.00%) Volume: 171.45k 4:00 PM EST Jan 17, 2020
Business Description:
Pluristem Therapeutics Inc is a bio-therapeutics company. It is engaged in developing off-the-shelf allogeneic cell therapy products for treatment of ischemic & inflammatory, cardiovascular, orthopedic, pulmonary, hematological, & women's health diseases.
Address: MATAM Advanced Technology Park, Building No.5, Haifa, ISR, 3508409
Telephone: +972 747108600 Website:
Facsimile: +972 747108787 Email: [email protected]
CEO: Yaky Yanay
Employees: 165 Market Cap: 64.1m
Issue Type: CS
Auditor: Kost Forer Gabbay & Kasierer
Last Audit: Unqualified Opinion with Explanation
Indices: Biotechnology
Industry Classifications
Sector: Healthcare CIK: 1158780
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Biological Product (except Diagnostic) Manufacturing (325414)
SIC: Biological Products, Except Diagnostic Substances (2836)